260 likes | 397 Views
FORESIGHT STUDY Future Trends and Challenges in Pathogenomics. JUDITH SIMON & SVEN POMPE PROGRAMME GROUP MUT. OBJECTIVES. Overview on future trends and challenges in research on human-pathogenic microorganisms (bacteria & fungi) Developments in basic research Diagnostics & therapy
E N D
FORESIGHT STUDYFuture Trends and Challenges in Pathogenomics JUDITH SIMON & SVEN POMPE PROGRAMME GROUP MUT
OBJECTIVES • Overview on future trends and challenges in research on human-pathogenic microorganisms (bacteria & fungi) • Developments in basic research • Diagnostics & therapy • Public health • Research co-operations • Technology transfer & market development
STRUCTURE • Methods • Literature & internet research • Preliminary assessment • Expert survey • Results • Research foci • Methods, diagnostics & therapeutics • Challenges for research • Public health • Co-operations • Market development & technology transfer • Recommendations • Discussion
METHODS • Triangulation: combination of literature and internet research with expert survey & interviews • "Triangulation [...] reduces the risk of systematic distortions inherent in the use of only one method.“ Maxwell 1998
METHODS: Literature Research • Databases • PubMed • Medline • Important scientific journals • Keywords & combinations • pathogenomics, infectious disease, public health, bacteria, fungi, bioweapons, bioterrorism and/or human-pathogenic • Focus on reviews • Specialised articles on particular micro-organisms were excluded
METHODS: Internet Research • Internet research on national & international • Surveys • Experts • Institutions • Networks
METHODS: Preliminary Assessment • Addressee: • 62 members of the ERA-NET PathoGenoMicsfrom 17 countries • Questions • Contact partners and national institutions • National main foci in microbiological research • National newly emerging hot topics in pathogenomics • Existing foresight studies on pathogenomics or related subjects
METHODS: Expert Survey • Development and application of questionnaires with questions on • Basic research • Future prospects in diagnostics & therapy • Strengths and weaknesses in research • Important cooperations and projects • Technology transfer & market development • Public health
METHODS: Expert Survey A total of 329 experts was selected and contacted.
Table 1: Reply & return rates METHODS: Expert Survey
RESULTS: Trends in Methodology • Improvement of conventional methods • Microscopy • Serology • Novel technologies • High-throughput analyses • Real time approaches • Bioinformatics • Omic‘s
RESULTS: Trends in Omic`s • Systemic approach Proteomics Genomics Transcriptomics Metabolomics
RESULTS: Trends in Omic`s • Understanding of: • Infection • Pathogenesis Genomics Transcriptomics Proteomics Metabolomics
RESULTS: Trends in Diagnostics • Use of novel technologies • PCR • Sequence-based identification • Molecular strain typing • But tools need to be more ... • rapid • sensitive • specific • robust • affordable
RESULTS: Challenges for Therapeutics • Extension of databases & discovery of molecular strategies In order to ... • enable comprehensive statistical and comparative analyses • standardise & validate diagnostics • find novel targets • develop new vaccines • innovate antibiotic intervention • individualise therapy
RESULTS: Challenges for Research • Multidisciplinary research on • Ecology & environment • Population dynamics • Evolution & taxonomy • Epidemiology • Risk assessment
RESULTS: Challenges for Research • Basic research on infection & pathogenesis • Analysis of host-pathogen-interaction • Identification of signaling pathways • Analysis of metabolic interactions • Identification of virulence factors • Target identification • ...
„Infectious diseases account for [...] 25 % of global deaths (over 14 million deaths annually)“ (WHO 2000) RESULTS: Public Health - Risks • Major risks are • Multidrug resistance (cf. tuberculosis) • Nosocomial infections • Bioterrorism
RESULTS: Public Health Measures • Surveillance systems • Action plans for emergencies • Vaccination strategies • Rapid and early diagnostics
Table 2: Co-operations and global players (N=30) RESULTS: Co-operations What are the most important research partners for scientists in pathogenomics?
Barriers High R&D costs Limited market size for vaccines and antibiotic products compared to the market for diseases of civilisation Opportunities Public-private partnerships Subcontracting with SME`s for preclinical studies Public funding for orphan drugs RESULTS: Market Development & Technology Transfer
RECOMMENDATIONS 1. Establish a European surveillance system 2. Reduce the misuse of pesticides in agriculture and animal technology 3. Create a European Competence Center for epidemiological research and modelling 4. Create an R&D programme that is specifically tailored to support public-private partnerships 5. Create structures for early warning and rapid response to emergencies
RECOMMENDATIONS 6. Develop comparative risk assessment strategies for setting national health priorities 7. Reconsider work-sharing between research institutes and universities 8. Foster cooperations between microbiological researchers and clinicians 9. Foster inclusion of ecological aspects into microbiology 10. Improve transparency about the function of different networks on pathogenomics 11. Conduct a study on industrial research objectives and economic interests
THANK YOU VERY MUCH FOR YOUR ATTENTION! The complete report on FUTURE TRENDS AND CHALLENGES IN PATHOGENOMICS will soon be available at http://www.pathogenomics-era.net
RECOMMENDATIONS 1. Establish a European surveillance system 2. Reduce the misuse of pesticides in agriculture and animal technology 3. Create a European Competence Center for epidemiological research and modelling 4. Create an R&D programme that is specifically tailored to support public-private partnerships 5. Create structures for early warning and rapid response to emergencies 6. Develop comparative risk assessment strategies for setting national health priorities 7. Reconsider work-sharing between research institutes and universities 8.Foster cooperations between microbiological researchers and clinicians 9. Foster inclusion of ecological aspects into microbiology 10. Improve transparency about the function of different networks on pathogenomics 11. Conduct a study on industrial research objectives and economic interests